Aytu Bioscience Stock Technical Analysis
| AYTU Stock | USD 2.60 0.02 0.78% |
As of the 1st of February, Aytu BioScience shows the Downside Deviation of 3.42, risk adjusted performance of 0.0762, and Mean Deviation of 2.47. Aytu BioScience technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Aytu BioScience Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Aytu, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AytuAytu BioScience's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Aytu BioScience Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 9.33 | Buy | 1 | Odds |
Most Aytu analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Aytu stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Aytu BioScience, talking to its executives and customers, or listening to Aytu conference calls.
Is there potential for Pharmaceuticals market expansion? Will Aytu introduce new products? Factors like these will boost the valuation of Aytu BioScience. If investors know Aytu will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Aytu BioScience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.23) | Revenue Per Share | Quarterly Revenue Growth (0.16) | Return On Assets | Return On Equity |
The market value of Aytu BioScience is measured differently than its book value, which is the value of Aytu that is recorded on the company's balance sheet. Investors also form their own opinion of Aytu BioScience's value that differs from its market value or its book value, called intrinsic value, which is Aytu BioScience's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Aytu BioScience's market value can be influenced by many factors that don't directly affect Aytu BioScience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Aytu BioScience's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aytu BioScience represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Aytu BioScience's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Aytu BioScience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aytu BioScience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aytu BioScience.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in Aytu BioScience on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding Aytu BioScience or generate 0.0% return on investment in Aytu BioScience over 90 days. Aytu BioScience is related to or competes with ProPhase Labs, Biofrontera, Ekso Bionics, TherapeuticsMD, Adlai Nortye, EnVVeno Medical, and OSR Holdings. Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics a... More
Aytu BioScience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aytu BioScience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aytu BioScience upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.42 | |||
| Information Ratio | 0.0802 | |||
| Maximum Drawdown | 12.75 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 4.69 |
Aytu BioScience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aytu BioScience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aytu BioScience's standard deviation. In reality, there are many statistical measures that can use Aytu BioScience historical prices to predict the future Aytu BioScience's volatility.| Risk Adjusted Performance | 0.0762 | |||
| Jensen Alpha | 0.2605 | |||
| Total Risk Alpha | 0.1341 | |||
| Sortino Ratio | 0.0728 | |||
| Treynor Ratio | 0.4199 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aytu BioScience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Aytu BioScience February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0762 | |||
| Market Risk Adjusted Performance | 0.4299 | |||
| Mean Deviation | 2.47 | |||
| Semi Deviation | 3.19 | |||
| Downside Deviation | 3.42 | |||
| Coefficient Of Variation | 1055.76 | |||
| Standard Deviation | 3.11 | |||
| Variance | 9.65 | |||
| Information Ratio | 0.0802 | |||
| Jensen Alpha | 0.2605 | |||
| Total Risk Alpha | 0.1341 | |||
| Sortino Ratio | 0.0728 | |||
| Treynor Ratio | 0.4199 | |||
| Maximum Drawdown | 12.75 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 4.69 | |||
| Downside Variance | 11.73 | |||
| Semi Variance | 10.17 | |||
| Expected Short fall | (2.50) | |||
| Skewness | (0.24) | |||
| Kurtosis | (0.52) |
Aytu BioScience Backtested Returns
Aytu BioScience appears to be moderately volatile, given 3 months investment horizon. Aytu BioScience secures Sharpe Ratio (or Efficiency) of 0.0988, which signifies that the company had a 0.0988 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Aytu BioScience, which you can use to evaluate the volatility of the firm. Please makes use of Aytu BioScience's Risk Adjusted Performance of 0.0762, downside deviation of 3.42, and Mean Deviation of 2.47 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Aytu BioScience holds a performance score of 7. The firm shows a Beta (market volatility) of 0.68, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Aytu BioScience's returns are expected to increase less than the market. However, during the bear market, the loss of holding Aytu BioScience is expected to be smaller as well. Please check Aytu BioScience's potential upside, as well as the relationship between the accumulation distribution and period momentum indicator , to make a quick decision on whether Aytu BioScience's price patterns will revert.
Auto-correlation | -0.26 |
Weak reverse predictability
Aytu BioScience has weak reverse predictability. Overlapping area represents the amount of predictability between Aytu BioScience time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aytu BioScience price movement. The serial correlation of -0.26 indicates that nearly 26.0% of current Aytu BioScience price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.26 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Aytu BioScience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Aytu BioScience Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Aytu BioScience volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Aytu BioScience Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Aytu BioScience on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Aytu BioScience based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Aytu BioScience price pattern first instead of the macroeconomic environment surrounding Aytu BioScience. By analyzing Aytu BioScience's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Aytu BioScience's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Aytu BioScience specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 131.74 | 171.31 | 154.17 | 84.43 | PTB Ratio | 0.57 | 0.72 | 3.34 | 3.5 |
Aytu BioScience February 1, 2026 Technical Indicators
Most technical analysis of Aytu help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Aytu from various momentum indicators to cycle indicators. When you analyze Aytu charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0762 | |||
| Market Risk Adjusted Performance | 0.4299 | |||
| Mean Deviation | 2.47 | |||
| Semi Deviation | 3.19 | |||
| Downside Deviation | 3.42 | |||
| Coefficient Of Variation | 1055.76 | |||
| Standard Deviation | 3.11 | |||
| Variance | 9.65 | |||
| Information Ratio | 0.0802 | |||
| Jensen Alpha | 0.2605 | |||
| Total Risk Alpha | 0.1341 | |||
| Sortino Ratio | 0.0728 | |||
| Treynor Ratio | 0.4199 | |||
| Maximum Drawdown | 12.75 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 4.69 | |||
| Downside Variance | 11.73 | |||
| Semi Variance | 10.17 | |||
| Expected Short fall | (2.50) | |||
| Skewness | (0.24) | |||
| Kurtosis | (0.52) |
Aytu BioScience February 1, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Aytu stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.05 | ||
| Daily Balance Of Power | 0.14 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 2.61 | ||
| Day Typical Price | 2.61 | ||
| Price Action Indicator | 0.00 | ||
| Market Facilitation Index | 0.14 |
Additional Tools for Aytu Stock Analysis
When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.